A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care
Abstract Cervical cancer is a leading cause of death for women in low-resource settings despite being preventable through human papillomavirus (HPV) vaccination, early detection, and treatment of precancerous lesions. The World Health Organization recommends high-risk HPV (hrHPV) as the preferred ce...
Main Authors: | Megan M. Chang, Ariel Ma, Emilie Newsham Novak, Maria Barra, Kathryn A. Kundrod, Jane Richards Montealegre, Michael E. Scheurer, Philip E. Castle, Kathleen Schmeler, Rebecca Richards-Kortum |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-47582-y |
Similar Items
-
Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing.
by: Kathryn A Kundrod, et al.
Published: (2023-01-01) -
Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing
by: Kathryn A. Kundrod, et al.
Published: (2023-01-01) -
The Engineering Design Primer /
by: Richards, K.L., author
Published: (2020) -
Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors
by: Chang Ma, et al.
Published: (2024-02-01) -
Biomedical engineering for global health /
by: 272297 Richards-Kortum, Rebecca
Published: (2010)